New Drug ApprovalFDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer FDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer Read Post »
Health TidingsFDA Issues Complete Response Letter for Chiesi’s Idebenone in Rare Vision... FDA Issues Complete Response Letter for Chiesi’s Idebenone in Rare Vision... Read Post »
New Drug ApprovalEuropean Commission Approves Incyte’s Zynyz Combination Therapy for First... European Commission Approves Incyte’s Zynyz Combination Therapy for First... Read Post »
Health TidingsDr. Vinay Prasad to Step Down as FDA CBER Director After Year of Regulatory... Dr. Vinay Prasad to Step Down as FDA CBER Director After Year of Regulatory... Read Post »
Food WellnessWhy You Should Always Wash Grapes Before Eating: The Hidden Risks Why You Should Always Wash Grapes Before Eating: The Hidden Risks Read Post »
Health TidingsSavara’s MOLBREEVI Clears FDA Day 74 Milestone; No Advisory Committee Pla... Savara’s MOLBREEVI Clears FDA Day 74 Milestone; No Advisory Committee Pla... Read Post »
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study JOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study Read Post »
Health TidingsNemluvio and Relfydess Emerge as Key Drivers in Galderma’s Record 2025 Pe... Nemluvio and Relfydess Emerge as Key Drivers in Galderma’s Record 2025 Pe... Read Post »
Health Tidings Policy & AcquisitionsTenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Tenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Read Post »
Health Tidings Policy & AcquisitionsServier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Servier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Read Post »
Clinical TrialsHelus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Helus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Read Post »
New Drug ApprovalFDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... FDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... Read Post »
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Roche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Read Post »
Clinical TrialsRoche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Roche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Read Post »
Clinical TrialsFDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... FDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... Read Post »
Health TidingsOutlook Therapeutics Charts Regulatory Path Forward for LYTENAVA After FDA ... Outlook Therapeutics Charts Regulatory Path Forward for LYTENAVA After FDA ... Read Post »
ResearchGLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... GLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... Read Post »
Clinical TrialsFibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers FibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers Read Post »
New Drug ApprovalJ&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... J&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... Read Post »
Health TidingsCanada Taps CSL Seqirus for Cell-Based Pandemic Flu Vaccines in New Prepare... Canada Taps CSL Seqirus for Cell-Based Pandemic Flu Vaccines in New Prepare... Read Post »
Health TidingsOral Epinephrine on Track: Aquestive Maps Path Forward for Anaphylm Oral Epinephrine on Track: Aquestive Maps Path Forward for Anaphylm Read Post »
Health Tidings Policy & AcquisitionsSanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Sanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Read Post »
Clinical TrialsBiogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Biogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Read Post »
Health TidingsBridging Obesity Care Gaps: Lilly’s New Employer Platform Bridging Obesity Care Gaps: Lilly’s New Employer Platform Read Post »
New Drug ApprovalGlenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Glenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Read Post »
Health Tidings Policy & AcquisitionsDuvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Duvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Read Post »
Clinical TrialsAmpreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Ampreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Read Post »
Health Tidings Policy & AcquisitionsGSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... GSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... Read Post »
Policy & AcquisitionsUCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... UCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... Read Post »
Health TidingsModerna Settles Global Patent Litigation with Arbutus and Genevant for $950... Moderna Settles Global Patent Litigation with Arbutus and Genevant for $950... Read Post »
Health TidingsFDA Cracks Down on Illegal Marketing of Compounded GLP-1 Drugs, Issues Warn... FDA Cracks Down on Illegal Marketing of Compounded GLP-1 Drugs, Issues Warn... Read Post »
Health TidingsJapan Grants Orphan Drug Status to Sanofi’s Rilzabrutinib for Rare IgG4-R... Japan Grants Orphan Drug Status to Sanofi’s Rilzabrutinib for Rare IgG4-R... Read Post »
New Drug ApprovalAgios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Agios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Read Post »
Health TidingsFDA Grants Priority Review to Takeda’s Rusfertide for Polycythemia Vera FDA Grants Priority Review to Takeda’s Rusfertide for Polycythemia Vera Read Post »
Drugs Safety AlertKyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Kyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Read Post »
Clinical TrialsIntellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Intellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Read Post »
Health TidingsJohnson & Johnson Advances Nipocalimab in Lupus with Latest FDA Fast Tr... Johnson & Johnson Advances Nipocalimab in Lupus with Latest FDA Fast Tr... Read Post »
Health TidingsOno Leverages Congruence Revenir™ for Neurology, Immunology Breakthroughs Ono Leverages Congruence Revenir™ for Neurology, Immunology Breakthroughs Read Post »
Health TidingsAtara and Pierre Fabre Seek FDA Type A Meeting to Advance Tab-Cel After CRL Atara and Pierre Fabre Seek FDA Type A Meeting to Advance Tab-Cel After CRL Read Post »
Health TidingsFDA Grants Rare Public Hearing on Vanda’s HETLIOZ® Jet Lag Approval ... FDA Grants Rare Public Hearing on Vanda’s HETLIOZ® Jet Lag Approval ... Read Post »
Policy & AcquisitionsCullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Cullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Read Post »
Clinical TrialsMerck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Merck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Read Post »
Health TidingsPhase 3 Setback for Aardvark’s ARD-101 as HERO Enrollment Freezes Phase 3 Setback for Aardvark’s ARD-101 as HERO Enrollment Freezes Read Post »
Clinical Trials55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... 55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... Read Post »
New Drug ApprovalHERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC HERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC Read Post »
Health TidingsIntellia Gains Complete FDA Greenlight for Nex-z ATTR Trials Post-Hold Reso... Intellia Gains Complete FDA Greenlight for Nex-z ATTR Trials Post-Hold Reso... Read Post »
Health TidingsJohnson & Johnson Unveils Promising Phase 1b Data for Pasritamig Plus D... Johnson & Johnson Unveils Promising Phase 1b Data for Pasritamig Plus D... Read Post »
New Drug ApprovalFDA Approves Once-Weekly YUVIWEL® for Pediatric Achondroplasia FDA Approves Once-Weekly YUVIWEL® for Pediatric Achondroplasia Read Post »
Clinical TrialsAbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... AbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... Read Post »
Health TidingsHuntington’s Hope Dims? FDA Urges Sham-Controlled Trial for uniQure AMT-1... Huntington’s Hope Dims? FDA Urges Sham-Controlled Trial for uniQure AMT-1... Read Post »
